http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103655207-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K6-083 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 |
filingDate | 2013-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103655207-B |
titleOfInvention | Gear division binding agent that medicine carrying mesoporous silicon oxide strengthens and preparation method thereof |
abstract | The present invention relates to gear division binding agent of a kind of medicine carrying mesoporous silicon oxide enhancing and preparation method thereof. This binding agent comprises each component of following parts by weight: resinous principle: 40-60%; Diluted composition: 35-50%; Acid monomer: 2-10%; Light trigger: 0.2%-0.5%; Promoter: 0.1%-0.3%; Polymerization inhibitor: trace; Mesoporous silicon: 1-10%. Described binding agent not only has higher intensity, also there is medicine-releasing performance, thereby play that bag carries and the advantage of the medicine such as controlled release antiseptic, anti-inflammatory drug, haemostatic medicament, make binding agent can not only play cementation, and there is certain treatment and the effect of host defense against bacterial infection, will can be used for clinical dentine binding agent. |
priorityDate | 2013-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.